172 related articles for article (PubMed ID: 2467224)
21. Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT.
Hillegaart V; Ahlenius S; Larsson K
Behav Brain Res; 1991 Feb; 42(2):169-80. PubMed ID: 1829365
[TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe.
Fletcher PJ
Brain Res; 1991 Jun; 552(2):181-9. PubMed ID: 1833034
[TBL] [Abstract][Full Text] [Related]
23. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.
Kennett GA; Marcou M; Dourish CT; Curzon G
Eur J Pharmacol; 1987 Jun; 138(1):53-60. PubMed ID: 2442002
[TBL] [Abstract][Full Text] [Related]
24. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
[TBL] [Abstract][Full Text] [Related]
25. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
[TBL] [Abstract][Full Text] [Related]
26. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
Beer M; Kennett GA; Curzon G
Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
[TBL] [Abstract][Full Text] [Related]
27. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
28. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
29. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
Fletcher PJ; Davies M
Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
[TBL] [Abstract][Full Text] [Related]
30. Functional topography of brain serotonergic pathways in the rat.
Hillegaart V
Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus.
Lum JT; Piercey MF
Eur J Pharmacol; 1988 Apr; 149(1-2):9-15. PubMed ID: 2969339
[TBL] [Abstract][Full Text] [Related]
32. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.
Invernizzi RW; Cervo L; Samanin R
Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083
[TBL] [Abstract][Full Text] [Related]
33. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
34. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
Hutson PH; Dourish CT; Curzon G
Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
[TBL] [Abstract][Full Text] [Related]
35. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
Giral P; Martin P; Soubrié P; Simon P
Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
[TBL] [Abstract][Full Text] [Related]
37. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat.
Hillegaart V; Hjorth S; Ahlenius S
J Neural Transm Gen Sect; 1990; 81(2):131-45. PubMed ID: 2141990
[TBL] [Abstract][Full Text] [Related]
38. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity.
Invernizzi R; Carli M; Di Clemente A; Samanin R
J Neurochem; 1991 Jan; 56(1):243-7. PubMed ID: 1824782
[TBL] [Abstract][Full Text] [Related]
39. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
Davis M; Cassella JV; Kehne JH
Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
[TBL] [Abstract][Full Text] [Related]
40. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat.
Schreiber R; de Vry J
J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]